TP53 Mutations and Lung Cancer: Not All Mutations Are Created Equal

被引：26

作者：

Govindan, Ramaswamy ^{[1
,2
]}

Weber, Jason ^{[1
,2
]}

机构：

[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA

[2] Washington Univ, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA

来源：

CLINICAL CANCER RESEARCH | 2014年 / 20卷 / 17期

关键词：

P53; MUTATIONS; MUTANT P53; SURVIVAL; CARCINOMA; RAS;

D O I：

10.1158/1078-0432.CCR-14-0899

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Mutations in TP53 are common in non-small cell lung cancer. Apart from the loss of tumor-suppressor functions, TP53 mutations may result in gain of function favoring cellular proliferation, inhibition of apoptosis, and genomic instability. Some TP53 mutations are more likely to affect the course of the disease than others. (C) 2014 AACR.

引用

页码：4419 / 4421

页数：3

共 50 条

[21] TP53 mutations in Romanian patients with colorectal cancer
Manirakiza, Felix
Yamada, Hidetaka
Iwashita, Yuji
Ishino, Keiko
Ishikawa, Rei
Kovacs, Zsolt
Osvath, Eva
Nzitakera, Augustin
Gurzu, Simona
Sugimura, Haruhiko
GENES AND ENVIRONMENT, 2023, 45 (01)
[22] The Repertoire of TP53 Mutations in Endometrioid Endometrial Cancer
Weigelt, B.
Hussein, Y. R.
Soslow, R. A.
MODERN PATHOLOGY, 2014, 27 : 311A - 311A
[23] TP53 mutations in head and neck cancer -: Reply
Koch, Wayne
Poeta, M. Luana
Manola, Judith
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11): : 1195 - 1195
[24] Clinical Outcomes and Correlates of TP53 Mutations and Cancer
Robles, Ana I.
Harris, Curtis C.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (03): : a001016
[25] Profile of TP53 gene mutations in sinonasal cancer
Holmila, Reetta
Bornholdt, Jette
Suitiala, Tuula
Cyr, Diane
Dictor, Michael
Steiniche, Torben
Wolff, Henrik
Wallin, Hakan
Luce, Daniele
Husgafvel-Pursiainen, Kirsti
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2010, 686 (1-2) : 9 - 14
[26] The Repertoire of TP53 Mutations in Endometrioid Endometrial Cancer
Weigelt, B.
Hussein, Y. R.
Soslow, R. A.
LABORATORY INVESTIGATION, 2014, 94 : 311A - 311A
[27] Therapeutic targeting of TP53 nonsense mutations in cancer
Strandgren, Charlotte
Wiman, Klas G.
UPSALA JOURNAL OF MEDICAL SCIENCES, 2024, 129
[28] In colorectal cancer, not all KRAS mutations are created equal
Rebecca Kirk
Nature Reviews Clinical Oncology, 2011, 8 (1) : 1 - 1
[29] Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
A Langerød
TI Andersen
I Bukholm
A-L Børresen Dale
Breast Cancer Research, 2 (Suppl 1)
[30] LUX-Lung trials—not all mutations are created equal
Lisa Hutchinson
Nature Reviews Clinical Oncology, 2015, 12 (3) : 127 - 127

← 1 2 3 4 5 →